Quantcast

CO2 SOLUTION & CODEXIS TO MAKE PRESENTATION ON CARBON CAPTURE PROGRAM AT BIO WORLD CONGRESS

May 5, 2011

TSX-V: CST
Outstanding shares: 60,261,136

Glenn Kelly, CO(2) Solution CEO also to present at conference investor session and appear
on the
Canal Argent morning program, En Affaires, to discuss CO(2) Solution and the conference

QUEBEC CITY, May 5 /PRNewswire/ – CO(2) Solution Inc. (TSXV: CST) announced today that the company will make a
joint presentation with Codexis, Inc. (Nasdaq: CDXS) on recent
developments related to their carbon capture technology program to
reduce carbon pollution from coal-fired power plants and other large
industrial sources of CO(2 )emissions.

The presentation is being made at the 2011 BIO World Congress on
Industrial Biotechnology & Bioprocessing in Toronto, Ontario, Canada on
May 9 at 8:45 a.m. Eastern Time. Presenting for CO(2) Solution and Codexis will be Jonathan Carley, Vice-President, Business
Development and Christopher Savile, Ph.D., Staff Scientist,
respectively. Further information can be found at http://www.bio.org/worldcongress/.

In January 2011 CO(2) Solution announced the extension of the carbon capture Joint
Development Agreement with Codexis. Program results to date have shown
that the combined CO(2) Solution / Codexis proprietary technologies have the potential to
significantly lower the cost barrier associated with conventional
technologies to capture carbon dioxide (CO(2)) from power and industrial effluent gases.

At the same conference, the following day, May 10(th)at 12 noon, Glenn Kelly, President & CEO of CO(2) Solution Inc. will present an overview of CO(2) Solution to investment community members attending the conference.

As a prelude to the conference, Mr. Kelly will be appearing on the Canal
Argent morning program, En Affaires hosted by Francois Gagnon on Friday May 6th at 10:10 am to discuss CO(2) Solution and the Bio World Conference.

The BIO World Congress on Industrial Biotechnology and Bioprocessing is
the world’s largest industrial biotechnology event for business
leaders, investors and policy makers in biofuels, biobased products,
and renewable chemicals. Entering its eighth year, the event is
expected to bring together more than 1,000 high-profile scientists,
executives, government officials and investors.

About CO(2) Solution Inc.
CO(2) Solution is an innovator in the field of enzyme-enabled carbon capture
and has been actively working to develop and commercialize the
technology for power plants and other large stationary sources of
carbon pollution. In the process, CO(2) Solution has built an extensive patent portfolio covering the use of
carbonic anhydrase, or analogues thereof, for the efficient
post combustion capture of carbon dioxide with low energy aqueous
solvents. Further information about CO(2) Solution can be found at www.co2solution.com.

CO(2) Solution Forward-looking Statements
Certain statements in this news release may be forward-looking. These
statements relate to future events or CO(2) Solution’s future economic performance and reflect the current
assumptions and expectations of management. Certain unknown factors may
affect the events, economic performance and results of operation
described herein. CO(2) Solution undertakes no obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be required under applicable
law.

Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.

SOURCE CO2 SOLUTION INC.


Source: newswire



comments powered by Disqus